Milliman：2025年药物依从性对商业保险患者医疗总成本的影响研究报告（英文版）

We performed an analysis of medication adherence in commercially insured patients aged 18 to 64 with diabetes, hypertension, or hyperlipidemia, and observed a stronger relationship between medication adherence and lower healthcare costs for patients with high risk scores. These results suggest that employers and healthcare providers may benefit from stratifying patients by imputing health risk scores into their claims data. This process will improve insights into the relationship between adhe